Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00271713
Recruitment Status : Completed
First Posted : January 4, 2006
Last Update Posted : January 28, 2009
Information provided by:
Charite University, Berlin, Germany

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2007
  Study Completion Date : September 2007